ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 148 filers reported holding ARCUS BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,913,485 | -11.3% | 329,442 | +0.4% | 0.00% | -20.0% |
| Q2 2023 | $6,664,321 | +12.5% | 328,130 | +1.0% | 0.01% | +25.0% |
| Q1 2023 | $5,923,257 | -12.9% | 324,740 | -1.3% | 0.00% | -20.0% |
| Q4 2022 | $6,803,864 | -23.8% | 329,007 | -3.6% | 0.01% | -28.6% |
| Q3 2022 | $8,926,000 | +6.2% | 341,206 | +2.8% | 0.01% | +16.7% |
| Q2 2022 | $8,407,000 | +3108.8% | 331,777 | +3891.5% | 0.01% | – |
| Q1 2022 | $262,000 | -24.5% | 8,312 | -3.1% | 0.00% | – |
| Q4 2021 | $347,000 | -29.3% | 8,580 | -39.1% | 0.00% | – |
| Q3 2021 | $491,000 | +9.4% | 14,079 | -14.0% | 0.00% | – |
| Q2 2021 | $449,000 | -31.7% | 16,362 | -30.1% | 0.00% | – |
| Q1 2021 | $657,000 | +5.1% | 23,414 | -2.8% | 0.00% | – |
| Q4 2020 | $625,000 | – | 24,080 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |